ArticleCanadian respiratory journal2024

Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors.

Chih-Yen Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.